Biblio
Mesenchymal stem cells reversibly de-differentiate myofibroblasts to fibroblast-like cells by inhibiting the TGF-β-SMAD2/3 pathway. Mol Med. 2023;29(1):59.
Stem cell-based therapy for COVID-19. Int Immunopharmacol. 2023;124(Pt A):110890.
. Validation of the imatinib-therapy failure model. Leukemia. 2023.